Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002093064 | SCV002380178 | likely benign | Bloom syndrome | 2023-04-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003365689 | SCV004072537 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-07-14 | criteria provided, single submitter | clinical testing | The c.2622G>A variant (also known as p.V874V), located in coding exon 12 of the BLM gene, results from a G to A substitution at nucleotide position 2622. This nucleotide substitution does not change the valine at codon 874. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may weaken the native splice donor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |